Lin JY - Search Results

1

Neutrophils as potential therapeutic targets for breast cancer.

Gong YT, Zhang LJ, Liu YC, Tang M, Lin JY, Chen XY, Chen YX, Yan Y, Zhang WD, Jin JM, Luan X. Gong YT, et al. Among authors: lin jy. Pharmacol Res. 2023 Dec;198:106996. doi: 10.1016/j.phrs.2023.106996. Epub 2023 Nov 14. Pharmacol Res. 2023. PMID: 37972723 Free article. Review.

2

Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins.

Lin J, Jin J, Shen Y, Zhang L, Gong G, Bian H, Chen H, Nagle DG, Wu Y, Zhang W, Luan X. Lin J, et al. Theranostics. 2021 Jul 13;11(17):8337-8349. doi: 10.7150/thno.62686. eCollection 2021. Theranostics. 2021. PMID: 34373745 Free PMC article. Review.

3

LncRNAs in tumor microenvironment: The potential target for cancer treatment with natural compounds and chemical drugs.

Liu QP, Lin JY, An P, Chen YY, Luan X, Zhang H. Liu QP, et al. Among authors: lin jy. Biochem Pharmacol. 2021 Nov;193:114802. doi: 10.1016/j.bcp.2021.114802. Epub 2021 Oct 19. Biochem Pharmacol. 2021. PMID: 34678226 Review.

4

Polymer chimera of stapled oncolytic peptide coupled with anti-PD-L1 peptide boosts immunotherapy of colorectal cancer.

Lu L, Zhang H, Zhou Y, Lin J, Gao W, Yang T, Jin J, Zhang L, Nagle DG, Zhang W, Wu Y, Chen H, Luan X. Lu L, et al. Theranostics. 2022 Apr 24;12(7):3456-3473. doi: 10.7150/thno.71129. eCollection 2022. Theranostics. 2022. PMID: 35547769 Free PMC article.

5

Biomimetic engineered nanocarriers inspired by viruses for oral-drug delivery.

Zhang JY, Liu XX, Lin JY, Bao XY, Peng JQ, Gong ZP, Luan X, Chen Y. Zhang JY, et al. Among authors: lin jy. Int J Pharm. 2022 Aug 25;624:121979. doi: 10.1016/j.ijpharm.2022.121979. Epub 2022 Jul 2. Int J Pharm. 2022. PMID: 35792230 Review.

6

Tachyplesin I and its derivatives: A pharmaco-chemical perspective on their antimicrobial and antitumor potential.

Lu S, Lin J, Jin J, Zhang L, Guan Y, Chen H, Wu Y, Zhang W, Luan X. Lu S, et al. Expert Opin Drug Discov. 2022 Dec;17(12):1407-1423. doi: 10.1080/17460441.2023.2157402. Expert Opin Drug Discov. 2022. PMID: 36503335 Review.

7

Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer.

Jin J, Wu Y, Zhao Z, Wu Y, Zhou YD, Liu S, Sun Q, Yang G, Lin J, Nagle DG, Qin J, Zhang Z, Chen HZ, Zhang W, Sun S, Luan X. Jin J, et al. JCI Insight. 2022 Nov 22;7(22):e160606. doi: 10.1172/jci.insight.160606. JCI Insight. 2022. PMID: 36509291 Free PMC article.

8

Targeted Protein Degradation Technology and Nanomedicine: Powerful Allies against Cancer.

Lin JY, Liu HJ, Wu Y, Jin JM, Zhou YD, Zhang H, Nagle DG, Chen HZ, Zhang WD, Luan X. Lin JY, et al. Small. 2023 May;19(18):e2207778. doi: 10.1002/smll.202207778. Epub 2023 Jan 24. Small. 2023. PMID: 36693784 Review.

9

A biomimetic nanoplatform for customized photothermal therapy of HNSCC evaluated on patient-derived xenograft models.

Wu Q, Chen L, Huang X, Lin J, Gao J, Yang G, Wu Y, Wang C, Kang X, Yao Y, Wang Y, Xue M, Luan X, Chen X, Zhang Z, Sun S. Wu Q, et al. Int J Oral Sci. 2023 Feb 10;15(1):9. doi: 10.1038/s41368-022-00211-2. Int J Oral Sci. 2023. PMID: 36765028 Free PMC article.

10

Fluoroindole chalcone analogues targeting the colchicine binding site of tubulin for colorectal oncotherapy.

Liu X, Jin J, Wu Y, Du B, Zhang L, Lu D, Liu Y, Chen X, Lin J, Chen H, Zhang W, Zhuang C, Luan X. Liu X, et al. Eur J Med Chem. 2023 Sep 5;257:115540. doi: 10.1016/j.ejmech.2023.115540. Epub 2023 Jun 2. Eur J Med Chem. 2023. PMID: 37301075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,479 results

Search Page

Filters